Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
All voices matter
Eli Lilly
Novo Nordisk demands price cuts from suppliers amid margin squeeze
Novo Nordisk has written to its suppliers requesting price reductions as the Danish pharmaceutical giant grapples with mounting cost pressures in a rapidly changing weight-loss drug market, according to a report by MedWatch on Wednesday. The correspondence gave suppliers only…
Eli Lilly says Trump pricing policy will delay obesity drug launches in Europe
Eli Lilly said on Tuesday that the Trump administration's most-favored-nation pricing policy will affect its plans to launch its weight-loss pill in Europe and Britain, with the rollout now expected in the second half of 2026 or early 2027. The…